RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:...
Source: prnewswire.com
Page 4 - Dror Ben Asher News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dror Ben Asher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dror Ben Asher Today - Breaking & Trending Today
RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:...
Source: prnewswire.com
Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance1 of $43.2 million as of June 30, 2022; Restated Q1/22: Net revenues of $13.1 million; Q3/22: Net revenues estimated2 to be between $16.5 million to $18.5 million; Operating loss estimated to be in the range of $5.5 million to $7.5 million; Q3/22 cash flow from operating activities is estimated positive for U.S. operations, before interest payments3 -- Commercial update: Upward trajectory continues with Talic
Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance1 of $43.2 million as of June 30, 2022; Restated Q1/22: Net... | November 7, 2022
Source: marketscreener.com
RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates
Financial update: Q2/22: Net revenues of $18.3 million; Operating loss of $9.2 million; Cash balance[1] of $43.2 million as of June 30, 2022; Restated Q1/22:...
Source: prnewswire.com
RedHill Biopharma Announces Q1/22 Highlights: On Track for Positive Cash from Operations in H2/22
Targeting positive cash from operations to start during H2/22[1] Focus on earlier achievement of operational profitability thanks to a recently implemented...
Source: prnewswire.com